Mark Frohlich - Net Worth and Insider Trading

Mark Frohlich Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mark Frohlich owns 1 companies in total, including Cyclacel Pharmaceuticals Inc (CYCC) .

Click here to see the complete history of Mark Frohlich’s form 4 insider trades.

Insider Ownership Summary of Mark Frohlich

Ticker Comapny Transaction Date Type of Owner
CYCC Cyclacel Pharmaceuticals Inc 2004-04-06 Medical Director and V.P.

Mark Frohlich Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Mark Frohlich Ownership Network

Ownership Network List of Mark Frohlich

No Data

Ownership Network Relation of Mark Frohlich

Insider Network Chart

Mark Frohlich Owned Company Details

What does Cyclacel Pharmaceuticals Inc do?

Who are the key executives at Cyclacel Pharmaceuticals Inc?

Mark Frohlich is the Medical Director and V.P. of Cyclacel Pharmaceuticals Inc. Other key executives at Cyclacel Pharmaceuticals Inc include director & E.V.P. & Finance & C.O.O. Paul Mcbarron , director & President & C.E.O. Spiro Rombotis , and Chief Medical Officer Mark Kirschbaum .

Cyclacel Pharmaceuticals Inc (CYCC) Insider Trades Summary

Over the past 18 months, Mark Frohlich made no insider transaction in Cyclacel Pharmaceuticals Inc (CYCC). Other recent insider transactions involving Cyclacel Pharmaceuticals Inc (CYCC) include a net purchase of 6,070 shares made by Spiro Rombotis , and a net purchase of 1,886 shares made by Paul Mcbarron .

In summary, during the past 3 months, insiders sold 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) were sold and 7,956 shares were bought by its insiders, resulting in a net purchase of 7,956 shares.

Cyclacel Pharmaceuticals Inc (CYCC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cyclacel Pharmaceuticals Inc Insider Transactions

No Available Data

Mark Frohlich Mailing Address

Above is the net worth, insider trading, and ownership report for Mark Frohlich. You might contact Mark Frohlich via mailing address: 1124 Columbia, Ste 130, Seattle Wa 98103.